Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin

Patient-reported symptoms correlate poorly with mucosal inflammation. Clinical decision-making may, therefore, not be based on objective evidence of disease activity. We conducted a study to determine factors associated with clinical decision-making in a secondary care inflammatory bowel disease (IBD) population, using a cross-sectional design.Decisions to request investigations or escalate medical therapy were recorded from outpatient clinic...